Penumbra Inc (PEN)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $12.65B
Last updated: Nov 17, 2026 at 11:05 AM ET
Penumbra Inc (PEN) P/E Ratio & Valuation History
Penumbra (PEN) trades at 77.4x trailing earnings and 8.1x sales. Its P/E of 77.4x is below its 5-year median of 90.7x. Its forward P/E is 55.9x. The median P/E across 8 similar companies is 22.9x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 38.5% higher over the next year. Its free cash flow yield is 1.6%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 77.4x |
| Forward P/E | 55.9x |
| Price to sales | 8.1x |
| Price to book | 8.0x |
| EV/EBITDA | 59.1x |
| Price to FCF | 63.1x |
| EV/FCF | 61.8x |
| PEG | 3.6 |
| FCF yield | 1.6% |
Historical Medians
Against its 10-year medians, its P/S is 18.2% below 9.9x and its P/B is 12.1% below 9.1x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 77.4x | 90.7x | N/A |
| P/S | 8.1x | 8.6x | 9.9x |
| P/B | 8.0x | 8.3x | 9.1x |
Valuation History
Over the 8 of the 10 year ends shown that have a P/E, its P/E ranged from 81.0x in 2025 to 795.5x in 2020. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $310.91 | 81.0x | 8.6x | 8.6x |
| 2024 | $237.48 | 82.7x | 7.7x | 8.1x |
| 2023 | $251.54 | 120.4x | 9.2x | 8.4x |
| 2022 | $222.46 | N/A | 10.0x | 8.7x |
| 2021 | $287.32 | 410.5x | 14.1x | 11.3x |
| 2020 | $175.00 | 795.5x | 11.3x | 10.2x |
| 2019 | $164.27 | 169.4x | 10.5x | 12.3x |
| 2018 | $122.20 | 239.6x | 9.5x | 10.5x |
| 2017 | $94.10 | 174.3x | 9.5x | 8.4x |
| 2016 | $63.80 | N/A | 7.4x | 7.4x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About PEN
What is PEN's forward P/E ratio?
Penumbra has a forward P/E ratio of 55.9x.
Is PEN stock overvalued?
GNG's valuation label for PEN is Undervalued. Its P/E of 77.4x compares with a median of 22.9x across 8 similar companies.
What is PEN's price to sales ratio?
Penumbra has a price to sales ratio of 8.1x.
What is Penumbra's average P/E ratio over 5 years?
Penumbra's median P/E over the last 5 years is 90.7x, from 54 month-end values through Oct 2026.
What is PEN's PEG ratio?
Penumbra has a PEG ratio of 3.6.
PEN pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts